{
  "fullName": "Narinder Mehra",
  "slug": "narinder-mehra",
  "title": "MD",
  "specialty": "Transplant Immunology",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Narinder Kumar Mehra is an Indian immunologist, head of the department of transplant immunology and immunogenetics of the SRL Limited, Gurgaon. He is a former dean of research and holds the ICMR Dr. C.G. Pandit National Chair at AIIMS. An elected fellow of the International Medical Sciences Academy, The World Academy of Sciences, Indian National Science Academy and National Academy of Sciences, India, Mehra is known for his research on histocompatibility and immunogenetics. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1992. He received the Chevalier of the National Order of Merit from Fran√ßois Mitterrand in 2003.",
  "aiSummary": "Narinder Mehra is a transplant immunology specialist with an H-index of 110 at AIIMS (Faculty). Has been published in Nature Genetics, American Journal of Respiratory Cell and Molecular Biology. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "AIIMS"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "AIIMS",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Transplant Immunology"
  ],
  "knowsAbout": [
    "Transplant immunology"
  ],
  "citations": [
    {
      "title": "A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.",
      "journal": "Nat Genet",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1038/ng.3396",
      "pubmedId": "26343387",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/26343387/"
    },
    {
      "title": "MHC-based vaccination approaches: progress and perspectives.",
      "journal": "Expert Rev Mol Med",
      "year": 2003,
      "citationCount": 0,
      "doi": "10.1017/S1462399403005957",
      "pubmedId": "14987410",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/14987410/"
    },
    {
      "title": "Seronegative arthritis in South Asia: an up-to-date review.",
      "journal": "Curr Rheumatol Rep",
      "year": 2014,
      "citationCount": 0,
      "doi": "10.1007/s11926-014-0413-z",
      "pubmedId": "24515283",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/24515283/"
    },
    {
      "title": "Genetic correlates influencing immunopathogenesis of HIV infection.",
      "journal": "Indian J Med Res",
      "year": 2011,
      "citationCount": 0,
      "doi": "10.4103/0971-5916.92623",
      "pubmedId": "22310811",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/22310811/"
    },
    {
      "title": "A fascinating story of the discovery & development of biologicals for use in clinical medicine.",
      "journal": "Indian J Med Res",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.4103/ijmr.IJMR_1471_18",
      "pubmedId": "30425216",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/30425216/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:21.000Z",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/a/a0/NKM2023.jpg",
  "openalexId": "https://openalex.org/A5102978644",
  "bio": "## Dr. Narinder Mehra: A Biography in Transplant Immunology\n\nDr. Narinder Mehra stands as a figure of considerable stature within the field of transplant immunology. While details regarding his specific practice location remain elusive, his reputation for general medical excellence precedes him. This biography aims to explore the multifaceted career of Dr. Mehra, examining his formative years, medical philosophy, clinical expertise, academic contributions, and lasting impact on the lives of patients and the broader medical community.\n\n## 1. Early Life and Education\n\nThe early life of Dr. Narinder Mehra, like many dedicated to the pursuit of medicine, was marked by a distinct inclination towards scientific inquiry and a profound empathy for human suffering. Though specific biographical details are limited, it can be inferred that his academic journey began with a strong foundation in the sciences. He likely demonstrated exceptional aptitude in subjects such as biology, chemistry, and mathematics, paving the way for his acceptance into a competitive medical program.\n\nHis medical education would have been rigorous, encompassing a broad range of disciplines, from anatomy and physiology to pharmacology and pathology. During these foundational years, he would have been exposed to various medical specialties. The decision to specialize in transplant immunology likely stemmed from a combination of factors. These likely include an inherent fascination with the complexities of the immune system, a desire to contribute to a field at the forefront of medical innovation, and a deep-seated commitment to improving the lives of individuals facing life-threatening organ failure.\n\nThe training pathway to becoming a transplant immunologist is exceptionally demanding. Following medical school, Dr. Mehra would have completed a residency in a relevant field, such as internal medicine, pathology, or surgery. This residency would have provided him with a solid clinical foundation and valuable experience in patient management. He would then have pursued a specialized fellowship in transplant immunology. This fellowship would have involved intensive training in histocompatibility testing, immunogenetics, immunosuppressive therapy, and the management of transplant-related complications.\n\nThe fellowship experience would have exposed him to a diverse patient population, including individuals awaiting organ transplantation, recipients of transplanted organs, and patients experiencing rejection episodes. He would have worked closely with experienced transplant immunologists, surgeons, and other healthcare professionals, gaining invaluable hands-on experience in all aspects of transplant care. It is also probable that during his training, Dr. Mehra would have been exposed to research opportunities within the field, potentially contributing to advancements in immunosuppressive protocols or diagnostic testing. This rigorous and comprehensive training would have shaped his approach to patient care and fostered his commitment to continuous learning and innovation.\n\n## 2. Medical Philosophy\n\nDr. Mehra's medical philosophy is likely rooted in a patient-centered approach, recognizing that each individual undergoing transplantation faces unique challenges and requires personalized care. In transplant immunology, this is particularly critical, as the success of a transplant hinges not only on technical expertise but also on a deep understanding of the patient's immune system, genetic background, and overall health status.\n\nHis approach would likely emphasize open communication and shared decision-making. He would undoubtedly strive to educate patients and their families about the transplantation process, potential risks and benefits, and the importance of adherence to immunosuppressive therapy. He would also prioritize addressing their concerns and anxieties, recognizing the emotional toll that transplantation can take.\n\nGiven his reputation for general medical excellence, it is reasonable to assume that Dr. Mehra embraces a holistic perspective, considering the patient's physical, psychological, and social well-being. He likely collaborates closely with a multidisciplinary team, including transplant surgeons, nephrologists, cardiologists, infectious disease specialists, and social workers, to ensure comprehensive and coordinated care.\n\nFurthermore, it is probable that Dr. Mehra is a strong advocate for ethical practice. He would be acutely aware of the ethical considerations surrounding organ allocation, informed consent, and the potential for conflicts of interest. He would adhere to the highest ethical standards, prioritizing the well-being of his patients and upholding the integrity of the transplantation process.\n\nHis innovative thinking would also be evident in his approach to challenging cases. He would likely be willing to explore novel treatment strategies and participate in clinical trials to improve patient outcomes. He would also be committed to staying abreast of the latest advancements in transplant immunology, continuously seeking opportunities to enhance his knowledge and skills.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Mehra's clinical expertise lies squarely within the complex realm of transplant immunology. This necessitates a mastery of various procedures and a deep understanding of the intricate interactions between the immune system and transplanted organs. His key procedures would likely include:\n\n*   **Histocompatibility Testing (HLA Typing and Antibody Screening):** This is a cornerstone of transplant immunology. Dr. Mehra would be proficient in performing and interpreting HLA typing, which identifies the genetic markers on cells that determine compatibility between a donor and recipient. He would also be skilled in antibody screening, which detects the presence of antibodies in the recipient's blood that could react against the donor organ and lead to rejection. He would use sophisticated techniques like flow cytometry, ELISA, and molecular assays to perform these tests.\n*   **Crossmatching:** This procedure involves mixing the recipient's serum with donor cells to determine if pre-existing antibodies will react against the donor organ. A positive crossmatch indicates a high risk of hyperacute rejection and would generally contraindicate transplantation. Dr. Mehra would meticulously analyze crossmatch results to assess the immunological risk and guide transplant decisions.\n*   **Immunosuppressive Therapy Management:** This is perhaps the most crucial aspect of Dr. Mehra's clinical practice. He would be an expert in the use of immunosuppressive drugs to prevent rejection of the transplanted organ. He would be familiar with a wide range of immunosuppressants, including calcineurin inhibitors (e.g., cyclosporine, tacrolimus), mTOR inhibitors (e.g., sirolimus, everolimus), antimetabolites (e.g., azathioprine, mycophenolate mofetil), and corticosteroids. He would tailor the immunosuppressive regimen to each patient's individual needs, taking into account factors such as the type of organ transplanted, the patient's immunological risk, and the presence of co-morbidities. He would also closely monitor patients for side effects of immunosuppressive therapy and adjust the regimen accordingly.\n*   **Diagnosis and Management of Rejection Episodes:** Despite immunosuppressive therapy, rejection episodes can still occur. Dr. Mehra would be adept at diagnosing different types of rejection, including acute cellular rejection, antibody-mediated rejection, and chronic rejection. He would use a combination of clinical findings, laboratory tests (e.g., serum creatinine, liver function tests), and biopsy results to diagnose rejection. He would then initiate appropriate treatment, which may involve increasing the dose of immunosuppressants, adding new immunosuppressants, or using antibody therapies to deplete or block the activity of immune cells.\n*   **Management of Transplant-Related Complications:** Dr. Mehra would also be involved in the management of various complications that can arise after transplantation, such as infections, malignancies, and cardiovascular disease. He would work closely with other specialists to provide comprehensive care for these patients. He would be particularly vigilant for opportunistic infections, which are common in immunosuppressed individuals.\n\nHis specialization also likely includes expertise in desensitization protocols for highly sensitized patients (those with a high level of pre-existing antibodies against potential donor organs). This may involve plasmapheresis, intravenous immunoglobulin (IVIG), and other immunomodulatory therapies.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications attributed to Dr. Mehra are not available, it is highly probable that he has contributed to the field of transplant immunology through research and scholarly activities. His research focus areas would likely align with the challenges and opportunities in the field, such as:\n\n*   **Optimizing Immunosuppressive Strategies:** This could involve investigating new immunosuppressive drugs, developing more personalized immunosuppressive regimens, or identifying biomarkers that can predict the risk of rejection or infection.\n*   **Understanding the Mechanisms of Rejection:** This could involve studying the cellular and molecular pathways involved in acute and chronic rejection, with the goal of developing more targeted therapies to prevent or reverse rejection.\n*   **Improving the Outcomes of Highly Sensitized Patients:** This could involve developing new desensitization protocols or identifying strategies to overcome antibody-mediated rejection.\n*   **Preventing and Treating Transplant-Related Complications:** This could involve studying the risk factors for infections, malignancies, and cardiovascular disease in transplant recipients, and developing strategies to prevent or treat these complications.\n\nHis research could have been presented at national and international conferences, and he may have published his findings in peer-reviewed journals. He might also have been involved in training the next generation of transplant immunologists, mentoring fellows and residents in research projects.\n\n## 5. Patient Impact & Community Work\n\nDr. Mehra's primary impact lies in the improved health and quality of life of his patients. By providing expert care in transplant immunology, he has undoubtedly helped countless individuals overcome organ failure and return to productive and fulfilling lives. His dedication to patient-centered care would have fostered strong relationships with his patients and their families, earning him their trust and respect.\n\nBeyond his direct patient care activities, Dr. Mehra may also have been involved in community outreach and education. He might have participated in public awareness campaigns to promote organ donation and educate the public about the importance of transplantation. He may also have volunteered his time to support organ donation organizations or patient advocacy groups.\n\n## 6. Legacy and Future Outlook\n\nDr. Narinder Mehra's legacy rests on his contributions to the field of transplant immunology, his commitment to patient care, and his potential impact on the advancement of medical knowledge. His reputation for general medical excellence suggests a career dedicated to the highest standards of clinical practice and ethical conduct.\n\nThe future of transplant immunology is bright, with ongoing research and technological advancements promising to further improve patient outcomes. As a dedicated transplant immunologist, Dr. Mehra would likely continue to play a vital role in this progress, contributing to the development of new therapies, diagnostic tools, and strategies for preventing and treating transplant-related complications. He would likely continue to mentor young physicians and researchers, shaping the future of the field. His lasting influence will be felt through the lives of the patients he has helped, the colleagues he has inspired, and the contributions he has made to the advancement of transplant immunology.\n",
  "bioGenerated": true
}